What is the share price of Fem Care Pharma Ltd (524608)?

Company share prices are keep on changing according to the market conditions. The current trading price of Fem Care Pharma Ltd (524608) on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of Fem Care Pharma?

The latest standalone P/E ratio of Fem Care Pharma as of 01-Jan-1970 is 18.50.

What is the P/B ratio of Fem Care Pharma Ltd (524608)?

The latest standalone P/B ratio of Fem Care Pharma Ltd (524608) as of 01-Jan-1970 is 5.81.

What is the 52-week high and low of Fem Care Pharma Ltd (524608)?

The 52-week high of Fem Care Pharma Ltd (524608) is Rs. 1010.00 and the 52-week low is Rs. 980.05.

Fem Care Pharma Ltd (524608) Share Analysis – Brand Strength, Quality & Valuation Zone & DeciZen Rating

Name: Fem Care Pharma Ltd (524608)
Brand: Fem Care Pharma

Fem Care Pharma Ltd (524608)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524608 NSE: Household & Personal Products | Small Cap | Fem Care Pharma Share Price

Fem Care Pharma Ltd (524608)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524608 NSE: Household & Personal Products | Small Cap | Fem Care Pharma Share Price

Key Metrics

Valuation Multiples

Market Cap

₹346 Cr.

Current Price

₹0

52-Week Low / High

₹980 / 1,010

TTM EPS

₹53

TTM Sales

₹119 Cr.

Book Value per Share

₹168.7

P/E Ratio

18.50

Industry PE

45.8

Price to Book (P/B)

5.81

Price to Sales (P/S)

2.90

EV/EBITDA

13.63

Dividend Yield

0.00%

Profitability Efficiency

Return on Equity (ROE)

34.50%

Return on Capital Employed (ROCE)

27.67%

Return on Assets (ROA)

14.53%

Operating Profit Margin

15.8%

Net Profit Margin

11.11%

Gross Profit Margin

16.5%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

14.67%

Operating Profit Growth (1 Year)

Improving versus 3-year growth rate

64.22%

Net Profit Growth (1 Year)

Improving versus 3-year growth rate

159.57%

Asset Quality

Promoter Holding

92.15%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹56 Cr.

Equity

₹3.5 Cr.

Face Value

₹10

All Time Low / High

₹6.35 / 1040.00

Fem Care Pharma stock performance

Key Ratios

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'00	Mar'01	Mar'02	Mar'03	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08	Mar'09	TTM
ROCE % ⓘ	12%	12%	-13.5%	15.5%	40.3%	49.1%	50.4%	60.6%	17.2%	27.7%	-
Growth Parameters ⓘ
Sales ⓘ	23.5	28.5	32.2	34.7	39.4	44.9	51.7	68.8	93.7	107	119
Sales YoY Gr.	-	21.2%	13.1%	7.8%	13.6%	13.9%	15%	33.2%	36.2%	14.7%	-
Adj EPS ⓘ	-0.4	0.9	-9.7	2.7	13.7	17.2	18.8	41.6	22.4	36.2	53
YoY Gr.	-	NA	-1189.9%	NA	407.8%	25.2%	9.4%	121.2%	-46.2%	62%	-
BVPS (₹) ⓘ	26.6	29.9	20.9	19.6	32.5	43.8	56	89.5	94.3	115.7	168.7
Adj Net Profit ⓘ	-0.1	0.3	-2.9	0.8	4.1	5.2	5.7	12.5	6.7	12.8	19
Cash Flow from Ops. ⓘ	-1.6	2.9	3.3	4.8	6.3	9.5	9.3	5	7.7	14.9	-
Debt/CF from Ops. ⓘ	-8	4.3	4.5	2.1	1.3	0.3	0.3	0.6	2.3	1.3	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	18.4%	22.2%	27.7%	14.7%
Adj EPS ⓘ	NA	21.5%	24.5%	62%
BVPSⓘ	17.8%	28.9%	27.3%	22.7%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

	Mar'00	Mar'01	Mar'02	Mar'03	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08	Mar'09	TTM
Return on Equity % ⓘ	-1.3	2.8	-35.6	13.1	52.4	45	37.6	57.1	24.1	36.7	37.3
Op. Profit Mgn % ⓘ	8.9	9.5	-8.5	14.6	17.4	18.4	17	21.6	11	15.8	17.2
Net Profit Mgn % ⓘ	-0.5	0.9	-9.1	2.3	10.5	11.5	10.9	18.2	7.2	11.9	15.7
Debt to Equity ⓘ	1.6	1.4	2.4	1.7	0.8	0.2	0.2	0.1	0.6	0.5	-
Working Cap Days ⓘ	155	134	124	119	94	76	83	107	117	127	0
Cash Conv. Cycle ⓘ	31	39	46	46	38	17	-2	9	13	16	0

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'00	Mar'01	Mar'02	Mar'03	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08	Mar'09
Sales	23.52	28.50	32.23	34.73	39.44	44.91	51.66	68.79	93.72	107.47
Operating Expenses ⓘ +	21.58	25.83	35.01	31.48	32.78	36.69	42.90	53.97	83.63	90.90
Manufacturing Costs	4.79	5.16	3.67	3.92	4.59	1.62	2.57	3.65	3.40	4.47
Material Costs	9.08	10.54	14.68	16.61	18.48	25.67	26.44	29.52	36.02	38.74
Employee Cost	2.07	2.49	3.07	2.98	3.91	3.62	4.31	5.92	10.90	12.35
Other Costs ⓘ	5.63	7.64	13.60	7.97	5.80	5.79	9.58	14.88	33.31	35.33
Operating Profit ⓘ	1.94	2.67	-2.78	3.25	6.66	8.21	8.76	14.83	10.09	16.57
Operating Profit Margin (%)	8.3%	9.4%	-8.6%	9.4%	16.9%	18.3%	17.0%	21.6%	10.8%	15.4%
Other Income ⓘ +	1.06	0.65	0.42	0.35	0.68	0.65	0.88	1.43	1.11	2.46
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	-2.88	-1.66
Interest ⓘ	1.88	2.08	1.90	1.71	0.65	0.24	0.22	0.23	0.82	1.13
Depreciation ⓘ	0.81	0.82	0.51	0.73	0.59	0.58	0.59	1.13	1.73	2.59
Profit Before Tax ⓘ	0.31	0.42	-4.77	1.16	6.11	8.04	8.83	14.90	5.78	13.65
Tax ⓘ	0.05	0.02	-1.83	1.62	2.11	2.90	3.13	2.37	1.19	1.71
Profit After Tax	0.26	0.40	-2.94	-0.46	4	5.14	5.70	12.53	4.60	11.94
PAT Margin (%)	1.1%	1.4%	-9.1%	-1.3%	10.2%	11.5%	11.0%	18.2%	4.9%	11.1%
Adjusted EPS (₹)	0.9	1.3	-9.8	-1.5	13.3	17.1	18.9	41.7	15.3	33.8
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	29.80%	31.70%	16.80%	45.80%	0%

Valuation of Fem Care Pharma - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'00	Mar'01	Mar'02	Mar'03	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08	Mar'09
Equity and Liabilities
Shareholders Fund +	9.40	10	6.41	5.95	9.77	13.18	16.86	26.93	28.37	40.83
Share Capital ⓘ	3.01	3.01	3.01	3.01	3.01	3.01	3.01	3.01	3.01	3.53
Reserves ⓘ	6.40	6.99	3.40	2.94	6.76	10.17	13.85	23.92	25.36	37.30
Debt +	12.52	12.27	14.96	10.01	7.88	2.87	3.03	3.13	17.88	19.24
Long Term Debt	12.52	12.27	14.96	10.01	7.88	2.87	3.03	3.13	17.88	19.24
Short Term Debt	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	4.97	4.53	5.67	4.73	2.58	5.29	6.90	8.06	9.09	9.27
Others Liabilities ⓘ	0.64	1.34	0.73	2.98	5.63	6.56	15.48	16.42	21.45	18.16
Total Liabilities ⓘ	27.53	28.14	27.77	23.67	25.86	27.90	42.27	54.53	76.80	87.51
Fixed Assets
Net Fixed Assets ⓘ +	8.75	9.36	9.48	8.63	9.08	9.20	9.11	19	34.18	33.49
Gross Block	10.82	12.21	11.56	11.28	12.34	12.14	12.45	23.38	40.35	40.59
Accumulated Depreciation	2.07	2.85	2.08	2.65	3.27	2.95	3.34	4.38	6.17	7.10
CWIP ⓘ	0.11	0.11	0	0	0.38	3.18	10.09	4.92	0.52	0.14
Investments ⓘ	3.56	5.28	5.22	3.52	3.52	4.97	4.96	3.76	0.95	5.51
Inventories	1.89	2.31	1.77	2.42	2.61	2.32	4.10	8.74	9.83	10.72
Trade Receivables	8.75	7.91	9.60	7.44	5.42	3.63	3.36	5.67	4.84	6.81
Cash Equivalents	0.52	0.48	0.53	0.46	2.23	0.86	2.40	1.49	6.12	8.16
Others Assets ⓘ	3.95	2.69	1.17	1.21	2.62	3.74	8.27	10.96	20.36	22.67
Total Assets ⓘ	27.53	28.14	27.77	23.67	25.86	27.90	42.27	54.53	76.80	87.51

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'00	Mar'01	Mar'02	Mar'03	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08	Mar'09
Cash Flow From Operating Activity ⓘ +	-1.57	2.86	3.29	4.81	6.32	9.54	9.28	5	7.74	14.89
PBT ⓘ	0.31	0.42	-0.34	1.21	6.11	8.04	8.83	14.90	5.78	13.65
Adjustment ⓘ	0.74	0.34	6.87	2.55	1.75	0.58	0.37	0.58	4.77	4.86
Changes in Working Capital ⓘ	-1.63	1.53	1.2	1.19	0.37	3.81	3.72	-8.73	-1.13	-2.19
Tax Paid ⓘ	-0.11	-0.05	0	-0.09	-1.90	-2.89	-3.63	-1.76	-1.68	-1.43
Cash Flow From Investing Activity ⓘ +	-3.05	-2.85	-3.82	1.87	-1.53	-4.82	-6.84	-3.71	-12.49	-7.24
Capex	0.20	-1.47	-4.13	-0.10	-1.87	-3.52	-7.43	-5.93	-12.38	-2.96
Net Investments	-3.50	-1.71	-0.04	1.70	0	-1.46	0.08	1.28	-0.68	-4.93
Others ⓘ	0.24	0.33	0.35	0.27	0.34	0.16	0.51	0.94	0.57	0.65
Cash Flow From Financing Activity ⓘ +	5.08	0.56	0.57	-6.75	-3.01	-6.10	-0.91	-2.19	8.65	-5.69
Net Proceeds from Shares ⓘ	0	0.20	0	0	0	0	0.04	0	0	0
Net Proceeds from Borrowing ⓘ	5.55	0.50	0.66	-2.03	-2.88	-5.29	0	0	0	0
Interest Paid ⓘ	0	0	-2.08	-1.71	-0.65	-0.24	-0.22	-0.23	-0.77	-1.13
Dividend Paid ⓘ	-0.42	0	0	0	0	-0.85	-0.89	-2.06	-2.11	-2.11
Others ⓘ	-0.04	-0.14	1.99	-3.01	0.51	0.28	0.16	0.09	11.52	-2.46
Net Cash Flow ⓘ	0.46	0.58	0.05	-0.07	1.78	-1.37	1.53	-0.91	3.90	1.96

Financial Ratio

PARTICULARS	Mar'00	Mar'01	Mar'02	Mar'03	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08	Mar'09
Ratios
ROE (%)	3.19	4.7	-38.54	-7.53	51.15	44.83	37.95	57.25	16.62	34.5
ROCE (%)	11.97	11.97	-13.52	15.47	40.27	49.13	50.37	60.59	17.18	27.67
Asset Turnover Ratio	1.13	1.22	1.28	1.4	1.7	1.82	1.6	1.45	1.44	1.32
PAT to CFO Conversion(x)	-6.04	7.15	N/A	N/A	1.58	1.86	1.63	0.4	1.68	1.25
Working Capital Days
Receivable Days	80.10	89.30	89.30	86.40	55.80	33.80	22.80	23.60	20.30	19.60
Inventory Days	32.60	22.50	20.80	21.20	21.80	18.40	20.90	33.50	35.90	34.60
Payable Days	174.80	164.50	116.50	101.10	63.30	46.70	69.60	82.30	82.70	82.70

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Fem Care Pharma Ltd FAQs

The current trading price of Fem Care Pharma on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Fem Care Pharma stood at ₹345.9 Cr

The latest P/E ratio of Fem Care Pharma as of 31-Dec-1969 is 18.50.

The latest P/B ratio of Fem Care Pharma as of 31-Dec-1969 is 5.81.

The 52-week high of Fem Care Pharma is ₹1,010 and the 52-week low is ₹980.0.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Fem Care Pharma is ₹119 ( Cr.) .

Data is not available for this company.

No data found

About Fem Care Pharma Ltd

Fem Care Pharma Limited (FPL) was originally incorporated as Fem Care Pharma Private Limited on September 3, 1986. Prior to the formation, the business was conducted as a partnership firm since 1982. Subsequently, it was converted to a public company on April 20, 1993 and the name was changed to its current name. The registered office of FPL is situated at Plot no. D-55, MIDC, Additional Industrial Area, Ambad, Nasik - 422010. The Corporate Office of FPL is situated at A/63-65 Mittal Tower, Nariman Point, Mumbai - 400 021 .

Business Profile:

FPL has three divisionsâ€™ i.e consumer products, pharmaceutical formulations and specialty chemicals. In the consumer products, FPL manufactures products such as cream bleaches, hair removing cream and liquid hand soaps which are marketed under its flagship brand â€œFEMâ€. FPL also markets fabric care products under the brand name â€œBambiâ€ and herbal anti- wrinkle cream under the brand â€œBotanicaâ€. In the pharmaceutical category, FPL primarily focuses on dermatology products by manufacturing various Aloe Vera-based creams, hair oils and other prescription-based products.

In the specialty chemicals, FPL manufactures bulk drugs and high value intermediates, which are also exported. FPL has two manufacturing facilities - at Nasik, Maharashtra and one at Baddi, Himachal Pradesh. FPL also exports its products to various countries.

Fem Care Pharma Ltd (524608)

Fem Care Pharma Ltd (524608)

Fem Care Pharma stock performance

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Fem Care Pharma - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Fem Care Pharma Ltd FAQs

About Fem Care Pharma Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Fem Care Pharma Ltd (524608)

Fem Care Pharma Ltd (524608)

Fem Care Pharma stock performance

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Fem Care Pharma - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Fem Care Pharma Ltd FAQs

What is the share price of Fem Care Pharma?

What is the market cap of Fem Care Pharma?

What is the P/E ratio of Fem Care Pharma?

What is the P/B ratio of Fem Care Pharma?

What is the 52-week high and low of Fem Care Pharma?

What is the TTM revenue of Fem Care Pharma?

Is a good quality company?

Is undervalued or overvalued?

Is a good buy now?

About Fem Care Pharma Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.